aTYR PHARMA INC Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
aTYR PHARMA INC quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q2 2024.
- aTYR PHARMA INC Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.01M, a 17% decline year-over-year.
- aTYR PHARMA INC Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.63M, a 69.9% increase year-over-year.
- aTYR PHARMA INC annual Nonoperating Income (Expense) for 2023 was $4.52M, a 326% increase from 2022.
- aTYR PHARMA INC annual Nonoperating Income (Expense) for 2022 was $1.06M, a 346% increase from 2021.
- aTYR PHARMA INC annual Nonoperating Income (Expense) for 2021 was $238K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)